Eli Lilly and Danish rival Novo Nordisk are racing to increase production in a weight-loss drug market estimated to reach about $150 billion by early 2030s.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
